Brodalumab: A Review of Safety Brodalumab: A Review of Safety

This article reviews the publicly available safety data for brodalumab, an interleukin-17R inhibitor approved for chronic plaque psoriasis. Is its safety profile similar to other IL-17 antagonists?Skin Therapy Letter

Source: Medscape Today Headlines - April 23, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news